Dose–response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults
- 2006-05-24
- RCT · n = 71
- European Journal of Clinical Nutrition 60(11)
- C. Larsen
- Susanne Dorthe Nielsen
- P. Kæstel
- Elke Brockmann
- M. Bennedsen
- Hanne Risager Christensen
- D. Eskesen
- B. Jacobsen
- Kim F. Michaelsen
- PubMed: 16721394
- DOI: 10.1038/sj.ejcn.1602450
15 Insights on
- Increased Persistence of Probiotics in Fecal Matter
- Increased Tolerability
- Improved Stool Consistency
- Improved Lipid Profile
- No Change in Lipid Profile
- Recovery of BB-12 from Feces
- Good Tolerability
- Increased Stool Consistency
- Reduced Stool Consistency
- Improved Tolerance to High Doses of Probiotics
- No Change in Serum Lipid Levels
- Increased Probiotic Tolerance
- Increased Colonization by Beneficial Bacteria (Bifidobacterium animalis subsp. lactis BB-12)
- Increased Dose Tolerance
- Increased Stool Looseness
- High evidence
- Highly Cited